CA
TPST icon

Commerzbank Aktiengesellschaft’s Tempest Therapeutics TPST Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14
Closed -$63K – 984
2016
Q4 		$63K Buy
14
+7
+100% +$87.2K ﹤0.01% 952
2016
Q3 		$149K Buy
+7
New +$127K ﹤0.01% 872

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TPST Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of Tempest Therapeutics (TPST) in Q1 2017, closing a stake of 14 shares — an estimated $63K sold.

Commerzbank Aktiengesellschaft first reported a position in TPST in Q3 2016 and held it in 2 quarters. The position peaked at $149K in Q3 2016. 63 funds tracked by Wall St. Rank hold TPST as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining Tempest Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 14 Tempest Therapeutics shares in Q1 2017, an estimated $63K.
  • Commerzbank Aktiengesellschaft first reported a position in Tempest Therapeutics in Q3 2016 and held it in 2 quarters.
  • Commerzbank Aktiengesellschaft's Tempest Therapeutics position peaked at $149K in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.